BENTONVILLE, Ark. - While Wal-Mart Stores' plan to sell 291 generic prescription drugs for $4 has not yet drawn supermarket pharmacies into a pricing war, it does have the industry rethinking its tactics.
Analysis of the retail giant's program has shown that direct impact on competing supermarkets and drug stores should be minimal. However, retailers are looking ahead to implications on customer loyalty, health services and reimbursement rates.
"Currently, we are not planning